CLINICAL_TRIALS
trial_result
· 2012-07-26
Clinical Trial Update: Ulimorelin Study of Efficacy and Safety (ULISES 008) [Phase 3]
Summary
Phase 3 trial ULISES 008 evaluating ulimorelin for gastrointestinal dysmotility has completed, summarizing efficacy and safety data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tranzyme, Inc. | Conditions: Gastrointestinal Dysmotility | Phase 3 | Status: COMPLETED